S. E. Owens

948 total citations
13 papers, 334 citations indexed

About

S. E. Owens is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine. According to data from OpenAlex, S. E. Owens has authored 13 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Pathology and Forensic Medicine. Recurrent topics in S. E. Owens's work include Lymphoma Diagnosis and Treatment (3 papers), Lanthanide and Transition Metal Complexes (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). S. E. Owens is often cited by papers focused on Lymphoma Diagnosis and Treatment (3 papers), Lanthanide and Transition Metal Complexes (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). S. E. Owens collaborates with scholars based in United Kingdom and United States. S. E. Owens's co-authors include I. Martin Sheldon, Jill M. Siegfried, E. Allan, H.L. Sharma, D. Crowther, A. Zaki, J Baer, B.W. Fox, Ivana N. Micallef and Jeremy Lawrance and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Cancer and British Journal of Haematology.

In The Last Decade

S. E. Owens

13 papers receiving 323 citations

Peers

S. E. Owens
F. Lehmann Germany
A.V. Kazansky United States
R. Ball Switzerland
Harish P. Dave United States
Melissa J. Brayman United States
J Warwick United Kingdom
Wade M. Junker United States
SD Smith United States
Y Tsuruta Japan
F. Lehmann Germany
S. E. Owens
Citations per year, relative to S. E. Owens S. E. Owens (= 1×) peers F. Lehmann

Countries citing papers authored by S. E. Owens

Since Specialization
Citations

This map shows the geographic impact of S. E. Owens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. E. Owens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. E. Owens more than expected).

Fields of papers citing papers by S. E. Owens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. E. Owens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. E. Owens. The network helps show where S. E. Owens may publish in the future.

Co-authorship network of co-authors of S. E. Owens

This figure shows the co-authorship network connecting the top 25 collaborators of S. E. Owens. A scholar is included among the top collaborators of S. E. Owens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. E. Owens. S. E. Owens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Sheldon, I. Martin & S. E. Owens. (2017). Postpartum uterine infection and endometritis in dairy cattle. Animal Reproduction. 14(3). 622–629. 73 indexed citations
2.
Owens, S. E., et al.. (2004). Differentiated thyroid cancer: radioiodine following lobectomy — a clinical feasibility study. Nuclear Medicine Communications. 25(3). 245–251. 16 indexed citations
3.
Li, Chenggang, Sarah Duff, Ali Khan, et al.. (2004). Perfusion of 99Tcm‐labeled CD105 Mab into kidneys from patients with renal carcinoma suggests that CD105 is a promising vascular target. International Journal of Cancer. 109(3). 436–441. 27 indexed citations
4.
Davies, Andrew, A. Z. S. Rohatiner, Stephen Howell, et al.. (2004). Tositumomab and Iodine I 131 Tositumomab for Recurrent Indolent and Transformed B-Cell Non-Hodgkin’s Lymphoma. Journal of Clinical Oncology. 22(8). 1469–1479. 80 indexed citations
5.
Cowan, Richard, Brian Murby, S. E. Owens, et al.. (2002). Autologous lymphocytes as vectors to target therapeutic radiation, using indium‐114m, in patients with lymphoid cell malignancy. British Journal of Haematology. 119(2). 459–466. 5 indexed citations
6.
Cooper, Rachel, Richard Cowan, S. E. Owens, et al.. (1999). Does salivary gland scintigraphy predict response to pilocarpine in patients with post-radiotherapy xerostomia?. European Journal of Nuclear Medicine and Molecular Imaging. 26(3). 220–225. 15 indexed citations
7.
Allan, E., et al.. (1999). Differentiated thyroid cancer. Nuclear Medicine Communications. 20(11). 983–990. 9 indexed citations
8.
Sharma, H.L., Richard Cowan, Brian Murby, et al.. (1997). Treatment of lymphoid cell malignancy with In-114m labelled autologous lymphocytes.. PubMed. 17(3B). 1815–21. 4 indexed citations
9.
Siegfried, Jill M. & S. E. Owens. (1989). Response of primary human lung carcinomas to autocrine growth factors produced by a lung carcinoma cell line. Lung Cancer. 5(17). 10–10. 35 indexed citations
10.
Cerny, Thomas, et al.. (1987). Immunoscintigraphy with 99mTc labelled F(ab?)2 fragments of an anti melanoma monoclonal antibody (225.28S) in patients with metastatic malignant melanoma. European Journal of Nuclear Medicine and Molecular Imaging. 13(3). 130–133. 11 indexed citations
12.
Scarffe, J H, et al.. (1985). Phase II trial of epirubicin in gastric cancer.. PubMed. 69(11). 1275–7. 9 indexed citations
13.
Sharma, H.L., N. Thatcher, J Baer, et al.. (1983). Blood clearance of radioactively labelled cis-diammine 1,1-cyclobutane dicarboxylate platinum(II) (CBDCA) in cancer patients. Cancer Chemotherapy and Pharmacology. 11(1). 5–7. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026